Betagenex

Betagenex is a preclinical Contract Research Organization (CRO) providing scientific expertise and drug discovery services in metabolic diseases to the pharmaceutical and biotech industries.

Based on our internationally recognized expertise in diabetes, obesity, pancreatic ß-cell function, and brain, we offer a complete array of preclinical services for compound testing and target validation using state-of-the-art approaches and experimental models.

Research Capabilities

Platform

  • Assessment of ß-cell function
  • Metabolic phenotyping
  • Targeted animal models

 

Innovation and new products

02.08.2013
New scientific publications

Two scientific publications from Pr Poitout and Pr Prentki's teams have been published regarding insulin secretion.

News

02.07.2013
Betagenex's founders will attend the French Speaking Society of Diabetes annual congress, March 26-29, 2013, France

During this annual congress, Pr Poitout will lead a symposium on the beta-cell as a therapeutic target for type II diabetes.